Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
13,849,849
-
Share change
-
+1,799,013
-
Total reported value
-
$50,545,862
-
Put/Call ratio
-
49%
-
Price per share
-
$3.65
-
Number of holders
-
77
-
Value change
-
+$6,687,288
-
Number of buys
-
51
-
Number of sells
-
22
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2023
As of 30 Jun 2023,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,849,849 shares.
The largest 10 holders included
Slate Path Capital LP, BlackRock Inc., VANGUARD GROUP INC, Bleichroeder LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Robertson Stephens Wealth Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, and Monaco Asset Management SAM.
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.